John Hadden

Insider Reports History

Location
Clearwater, FL
Signature
/s/ Natasha Giordano, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Hadden:

Form 4 holding Director

PLx Pharma Inc.

Security class
Stock Option (right to buy)
Shares / value
20,000
Estimated value
Report date
22 Feb 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John Hadden

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .